BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 8559526)

  • 21. Amniotic fluid alpha fetoprotein (AFAFP) and maternal serum alpha fetoprotein (MSAFP) in abdominal pregnancies: correlation with extent and site of placental implantation and clinical implications.
    Shumway JB; Greenspoon JS; Khouzami AN; Platt LD; Blakemore KJ
    J Matern Fetal Med; 1996; 5(3):120-3. PubMed ID: 8796780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
    Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS
    Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
    Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of fetal sex in amniotic fluid alphafetoprotein screening.
    Knippel AJ
    Prenat Diagn; 2002 Oct; 22(10):941-5. PubMed ID: 12378582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks associated with an elevated amniotic fluid alpha-fetoprotein level.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1991 Apr; 39(1):64-7. PubMed ID: 1714237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
    Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
    Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
    Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
    J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
    Spencer K
    Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
    Wax JR; Segna RA
    J Matern Fetal Med; 1997; 6(6):338-40. PubMed ID: 9438217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
    J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
    Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
    J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated levels of amniotic fluid alpha-fetoprotein: sonographic evaluation.
    Robbin M; Filly RA; Fell S; Goldstein RB; Callen PW; Goldberg JD; Golbus MS
    Radiology; 1993 Jul; 188(1):165-9. PubMed ID: 7685529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter: Alpha fetoprotein in amniotic fluid and maternal serum.
    Buffe D; Rimbaut C; Henrion R; Boue J; Boue A
    N Engl J Med; 1976 Jul; 295(1):51. PubMed ID: 58380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring.
    Boyd HA; Myrup C; Wohlfahrt J; Westergaard T; Nørgaard-Pedersen B; Melbye M
    Am J Epidemiol; 2006 Sep; 164(5):478-86. PubMed ID: 16790515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1).
    Krause TG; Christens P; Wohlfahrt J; Lei U; Westergaard T; Nørgaard-Pedersen B; Melbye M
    Obstet Gynecol; 2001 Feb; 97(2):277-82. PubMed ID: 11165595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.